Bausch Health Companies Inc. BHC-T BHC-N said on Wednesday it will add two directors from Icahn Group to its board, including Carl Icahn’s son Brett, weeks after the activist investor disclosed a nearly 8% stake in the Canadian drugmaker.
With the latest appointment of Bret Icahn and Steve Miller, both portfolio managers at Icahn Capital LP, the size of Bausch Health’s board will increase to 13 members.
The new members will be appointed to board committees - the finance and transactions committee and the committee assisting with evaluating strategic alternatives, including the potential spin of Bausch’s eye health business.
Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.